Steering the osteoclast through the demineralization-collagenolysis balance

Bone

Volumn 56, Issue 1, 2013, Pages 191-198

  Søe, Kent ^a   Merrild, Ditte Marie Horslev ^a   Delaissé, Jean Marie ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cathepsin K; Collagen; Mineral; Osteoclast; Resorption

Indexed keywords

CATHEPSIN K; COLLAGEN;

ARTICLE; BONE DEMINERALIZATION; BONE MATRIX; BONE METABOLISM; COLLAGEN DEGRADATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OBSERVATIONAL STUDY; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROCESSING;

CATHEPSIN K; COLLAGEN; MINERAL; OSTEOCLAST; RESORPTION;

BONE AND BONES; BONE DEMINERALIZATION, PATHOLOGIC; BONE RESORPTION; CATHEPSIN K; CELLS, CULTURED; COLLAGEN; HUMANS; HYDROLYSIS; MODELS, BIOLOGICAL; OSTEOCLASTS;

EID: 84880147845     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.06.007     Document Type: Article

References (57)

1. Delaisse J.M., Andersen T.L., Engsig M.T., Henriksen K., Troen T., Blavier L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities 1. Microsc Res Tech 2003, 61:504-513.
2. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., Rommerskirch W., et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A 1998, 95:13453-13458.
3. Tezuka K., Tezuka Y., Maejima A., Sato T., Nemoto K., Kamioka H., et al. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem 1994, 269:1106-1109.
4. Ding M. Microarchitectural adaptations in aging and osteoarthrotic subchondral bone issues. Acta Orthop Suppl 2010, 81:1-53.
5. Chavassieux P., Seeman E., Delmas P.D. Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev 2007, 28:151-164.
6. Seeman E., Delmas P.D. Bone quality - the material and structural basis of bone strength and fragility 3. N Engl J Med 2006, 354:2250-2261.
7. Dalle Carbonare L., Arlot M.E., Chavassieux P.M., Roux J.P., Portero N.R., Meunier P.J. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 2001, 16:97-103.
8. Kanis J.A., Johansson H., Oden A., Johnell O., de Laet C., Melton L.J., et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004, 19:893-899.
9. Parfitt A.M. Morphometry of bone resorption: introduction and overview. Bone 1993, 14:435-441.
10. Gentzsch C., Delling G., Kaiser E. Microstructural classification of resorption lacunae and perforations in human proximal femora. Calcif Tissue Int 2003, 72:698-709.
11. Boyde A., Maconnachie E., Reid S.A., Delling G., Mundy G.R. Scanning electron microscopy in bone pathology: review of methods, potential and applications. Scan Electron Microsc 1986, 1537-1554.
12. Gentzsch C., Pueschel K., Deuretzbacher G., Delling G., Kaiser E. First inventory of resorption lacunae on rods and plates of trabecular bone as observed by scanning electron microscopy. Calcif Tissue Int 2005, 76:154-162.
13. Vanderoost J., Soe K., Merrild D.M.H., Delaisse J.M., Lenthe G.H. Glucocorticoid-induced changes in the geometry of osteoclast resorption cavities affect trabecular bone stiffness. Calcif Tissue Int 2013, 92:240-250.
14. Lakkakorpi P.T., Vaananen H.K. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J Bone Miner Res 1991, 6:817-826.
15. Saltel F., Destaing O., Bard F., Eichert D., Jurdic P. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell 2004, 15:5231-5241.
16. Parikka V., Lehenkari P., Sassi M.L., Halleen J., Risteli J., Harkonen P., et al. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology 2001, 142:5371-5378.
17. Soe K., Delaisse J.M. Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle. J Bone Miner Res 2010, 25:2184-2192.
18. Everts V., Delaisse J.M., Korper W., Niehof A., Vaes G., Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases1. J Cell Physiol 1992, 150:221-231.
19. Leung P., Pickarski M., Zhuo Y., Masarachia P.J., Duong L.T. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. Bone 2011, 49:623-635.
20. Desmarais S., Masse F., Percival M.D. Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools. Biol Chem 2009, 390:941-948.
21. Blavier L., Delaisse J.M. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci 1995, 108:3649-3659.
22. Gauthier J.Y., Chauret N., Cromlish W., Desmarais S., Duong lT, Falgueyret J.P., et al. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg Med Chem Lett 2008, 18:923-928.
23. Li C.S., Deschenes D., Desmarais S., Falgueyret J.P., Gauthier J.Y., Kimmel D.B., et al. Identification of a potent and selective non-basic cathepsin K inhibitor. Bioorg Med Chem Lett 2006, 16:1985-1989.
24. Lund T., Soe K., Abildgaard N., Garnero P., Pedersen P.T., Ormstrup T., et al. First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro. Eur J Haematol 2010, 85:290-299.
25. Chambers T.J., Thomson B.M., Fuller K. Effect of substrate composition on bone resorption by rabbit osteoclasts. J Cell Sci 1984, 70:61-71.
26. Fuller K., Chambers T.J. Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 1995, 108(Pt 6):2221-2230.
27. Geblinger D., Geiger B., Addadi L. Surface-induced regulation of podosome organization and dynamics in cultured osteoclasts. Chembiochem 2009, 10:158-165.
28. Wijenayaka A.K., Colby C.B., Atkins G.J., Majewski P. Biomimetic hydroxyapatite coating on glass coverslips for the assay of osteoclast activity in vitro. J Mater Sci Mater Med 2009, 20:1467-1473.
29. Mulari M.T.K., Zhao H., Lakkakorpi P.T., Väänänen H.K. Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic 2003, 4:113-125.
30. Stenbeck G., Horton M.A. A new specialized cell-matrix interaction in actively resorbing osteoclasts. J Cell Sci 2000, 113:1577-1587.
31. Swanson C., Lorentzon M., Conaway H.H., Lerner U.H. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-{kappa}B (NF-{kappa}B) ligand, osteoprotegerin, and receptor activator of NF-{kappa}B in mouse calvarial bones. Endocrinology 2006, 147:3613-3622.
32. Furuyama N., Fujisawa Y. Regulation of collagenolytic cysteine protease synthesis by estrogen in osteoclasts. Steroids 2000, 65:371-378.
33. Imai Y., Youn M.Y., Kondoh S., Nakamura T., Kouzmenko A., Matsumoto T., et al. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann N Y Acad Sci 2009, 1173:E31-E39.
34. Mano H., Yuasa T., Kameda T., Miyazawa K., Nakamaru Y., Shiokawa M., et al. Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 1996, 223:637-642.
35. Troen B.R. The regulation of cathepsin K gene expression. Ann N Y Acad Sci 2006, 1068:165-172.
36. Song I., Kim J.H., Kim K., Jin H.M., Youn B.U., Kim N. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 2009, 583:2435-2440.
37. Sun L., Peng Y., Zaidi N., Zhu L.L., Iqbal J., Yamoah K., et al. Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. Am J Physiol Renal Physiol 2007, 292:F285-F291.
38. Bromme D., Wilson S. Role of cysteine cathepsins in extracellular proteolysis. Extracellular matrix degradation 2011, 23-51. Springer-Verlag, Berlin. W. Parks, R. Mecham (Eds.).
39. Percival M.D., Ouellet M., Campagnolo C., Claveau D., Li C. Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid. Biochemistry 1999, 38:13574-13583.
40. Borel O., Gineyts E., Bertholon C., Garnero P. Cathepsin K preferentially solubilizes matured bone matrix. Calcif Tissue Int 2012, 91:32-39.
41. Henriksen K., Leeming D.J., Byrjalsen I., Nielsen R.H., Sorensen M.G., Dziegiel M.H., et al. Osteoclasts prefer aged bone. Osteoporos Int 2007, 18:751-759.
42. Garnero P., Schott A.M., Prockop D., Chevrel G. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations. Bone 2009, 44:461-466.
43. Rauch F., Glorieux F.H. Osteogenesis imperfecta. Lancet 2004, 363:1377-1385.
44. Andersen T.L., del Carmen O.M., Kirkegaard T., Lenhard T., Foged N.T., Delaisse J.M. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. Bone 2004, 35:1107-1119.
45. Duong lT Therapeutic inhibition of cathepsin K[mdash]reducing bone resorption while maintaining bone formation 2012, 1. BoneKEy Rep.
46. Delaisse J.M., Boyde A., Maconnachie E., Ali N.N., Sear C.H., Eeckhout Y., et al. The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts 1. Bone 1987, 8:305-313.
47. Inui T., Ishibashi O., Inaoka T., Origane Y., Kumegawa M., Kokubo T., et al. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem 1997, 272:8109-8112.
48. Nakamura H., Sato G., Hirata A., Yamamoto T. Immunolocalization of matrix metalloproteinase-13 on bone surface under osteoclasts in rat tibia. Bone 2004, 34:48-56.
49. Mellis D.J., Itzstein C., Helfrich M.H., Crockett J.C. The skeleton: a multi-functional complex organ. The role of key signalling pathways in osteoclast differentiation and in bone resorption. J Endocrinol 2011, 211:131-143.
50. Yaroslavskiy B.B., Zhang Y., Kalla S.E., Palacios V.G., Sharrow A.C., Li Y., et al. NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP. J Cell Sci 2005, 118:5479-5487.
51. Burger E.H., Klein-Nulend J., Smit T.H. Strain-derived canalicular fluid flow regulates osteoclast activity in a remodelling osteon - a proposal. J Biomech 2003, 36:1453-1459.
52. Loveridge N., Fletcher S., Power J., Caballero-Alias A.M., Das-Gupta V., Rushton N., et al. Patterns of osteocytic endothelial nitric oxide synthase expression in the femoral neck cortex: differences between cases of intracapsular hip fracture and controls. Bone 2002, 30:866-871.
53. Nakamura I., Takahashi N., Sasaki T., Jimi E., Kurokawa T., Suda T. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. J Bone Miner Res 1996, 11:1873-1879.
54. Takahashi N., Ejiri S., Yanagisawa S., Ozawa H. Regulation of osteoclast polarization. Odontology 2007, 95:1-9.
55. Masarachia P.J., Pennypacker B.L., Pickarski M., Scott K.R., Wesolowski G.A., Smith S.Y., et al. Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys. J Bone Miner Res 2012, 27:509-523.
56. Hou P., Troen T., Ovejero M.C., Kirkegaard T., Andersen T.L., Byrjalsen I., et al. Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption. Bone 2004, 34:37-47.
57. Wilson S.R., Peters C., Saftig P., Bromme D. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. J Biol Chem 2009, 284:2584-2592.